Clinical Research Programs

Sheppard Pratt Health System

Schizophrenia

Brain Injuries

Traumatic Brain Injuries

Depression

Psychotic Disorders

Depressive Disorder

Anxiety Disorders

Chronic Brain Injury

Major Depressive Disorder

Wounds and Injuries

Valacyclovir

Tolcapone

MM120

Armodafinil

Cephalon

Indiana University

MindMed

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Sheppard Pratt Health System | Clinical Research Programs

Site insights

Work at this site?

Active trials

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Trial sponsors